Neuren Pharmaceuticals | NEU - Current Assets

Stock Price
12.79
Daily Change
-0.06 -0.47%
Monthly
2.48%
Yearly
-3.03%
Q2 Forecast
12.56

Neuren Pharmaceuticals reported AUD332.23M in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Akebia Therapeutics USD 243.48M 9.47M Mar/2026
Alaunos Therapeutics USD 970K 1.02M Mar/2026
Avita Medical AUD 35.49M 760K Dec/2025
Clinuvel Pharmaceuticals AUD 261.38M 1.59M Dec/2025
Dianthus Therapeutics USD 1.12B 710.47M Mar/2026
Genetic Signatures AUD 42.96M 5.02M Dec/2025
Ionis Pharmaceuticals USD 2.94B 52M Mar/2026
Medical Developments International AUD 33.75M 1.79M Dec/2025
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Organon & Co USD 4.93B 580M Mar/2026
Paradigm Biopharmaceuticals AUD 21.67M 2.46M Dec/2025
PYC Therapeutics AUD 153.74M 23.79M Dec/2025
Starpharma Holdings AUD 24.24M 1.68M Dec/2025
Tectonic Therapeutic USD 239.89M 17.47M Mar/2026
Telix Pharmaceuticals AUD 330.28M 67.73M Dec/2025
Viatris USD 10.92B 1.13B Mar/2026
Xeris Pharmaceuticals USD 251.68M 11.37M Mar/2026